Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MATTHEW MACALUSO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1417144023
CMS profile
431992
Location
BIRMINGHAM, AL

General Payments · PY2019–2024

$39,475.43

  • Reported across 61 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$8,215.00

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Honoraria $5,200.00 1
Travel and Lodging $2,178.98 10
Food and Beverage $836.02 4

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
LivaNova USA, Inc. $6,801.07 5
Abbott Laboratories $1,413.93 10

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $27,112.96 36
PY2020 $2,375.00 3
PY2021 $149.57 2
PY2022 $1,622.90 5
PY2024 $8,215.00 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019202020212022 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $100.67 09/17/2024 Food and Beverage Undisputed 01/23/2026 1125053075 CMS
Abbott Laboratories $149.48 09/17/2024 Travel and Lodging Undisputed 01/23/2026 1125408449 CMS
Abbott Laboratories $224.89 09/17/2024 Travel and Lodging Undisputed 01/23/2026 1125408451 CMS
Abbott Laboratories $9.02 09/17/2024 Travel and Lodging Undisputed 01/23/2026 1125408463 CMS
Abbott Laboratories $70.60 10/15/2024 Travel and Lodging Undisputed 01/23/2026 1125408453 CMS
Abbott Laboratories $345.16 10/15/2024 Travel and Lodging Undisputed 01/23/2026 1125408455 CMS
Abbott Laboratories $125.46 10/15/2024 Travel and Lodging Undisputed 01/23/2026 1125408457 CMS
Abbott Laboratories $82.66 10/15/2024 Travel and Lodging Undisputed 01/23/2026 1125408459 CMS
Abbott Laboratories $125.46 10/15/2024 Travel and Lodging Undisputed 01/23/2026 1125408461 CMS
Abbott Laboratories $180.53 12/09/2024 Food and Beverage Undisputed 01/23/2026 1125053077 CMS
LivaNova USA, Inc. $758.03 03/18/2024 Travel and Lodging Undisputed 01/23/2026 1152799531 CMS
LivaNova USA, Inc. $5,200.00 03/18/2024 Honoraria Undisputed 01/23/2026 1152799533 CMS
LivaNova USA, Inc. $288.22 03/18/2024 Travel and Lodging Undisputed 01/23/2026 1152799535 CMS
LivaNova USA, Inc. $389.01 03/18/2024 Food and Beverage Undisputed 01/23/2026 1152799537 CMS
LivaNova USA, Inc. $165.81 04/02/2024 Food and Beverage Undisputed 01/23/2026 1152799539 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.